Engineered botulinum neurotoxin
US-10844362-B2 · Nov 24, 2020 · US
Cross-Sectional Technologies
Cross-Sectional Technologies · Cooperative Patent Classification (CPC)
General tagging of emerging or interdisciplinary technologies.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | Y02A50/469 |
| Official title | — |
| Display label | Cross-Sectional Technologies (mapped technology topic) |
| Total patents | 49 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity appears to be declining based on the most recent years.
| Year | Patents |
|---|---|
| 2018 | 3 |
| 2019 | 26 |
| 2020 | 20 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
US-10822377-B2 · Nov 3, 2020 · US
Monomethylvaline compounds capable of conjugation to ligands
US-10808039-B2 · Oct 20, 2020 · US
Methods for treating neuromuscular junction-related diseases
US-2020323900-A1 · Oct 15, 2020 · US
High frequency application of botulinum toxin therapy
US-10792344-B2 · Oct 6, 2020 · US
Use of botulinum neurotoxin in the treatment of sialorrhea
US-2020297823-A1 · Sep 24, 2020 · US
Calcium channel agonists
US-10752629-B2 · Aug 25, 2020 · US
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
US-10745704-B2 · Aug 18, 2020 · US
Engineered Clostridium Botulinum Toxin Adapted To Deliver Molecules Into Selected Cells
US-2020255815-A1 · Aug 13, 2020 · US
Use of botulinum neurotoxin in the treatment of sialorrhea
US-10709772-B2 · Jul 14, 2020 · US
Methods and compositions relating to engineered microbial cells
US-10702559-B2 · Jul 7, 2020 · US
1,2,4-Oxadiazole Derivatives as Immunomodulators
US-2020199086-A1 · Jun 25, 2020 · US
Highly pure neurotoxic component of a botulinum toxin and uses thereof
US-10653754-B2 · May 19, 2020 · US
Monoclonal Antibodies to Programmed Death 1 (PD-1)
US-2020138945-A1 · May 7, 2020 · US
Novel recombinant clostridial neurotoxins with increased duration of effect
US-2020129587-A1 · Apr 30, 2020 · US
Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells
US-10633643-B2 · Apr 28, 2020 · US
Recombinant clostridial neurotoxins with increased duration of effect
US-10603353-B2 · Mar 31, 2020 · US
1,2,4-oxadiazole derivatives as immunomodulators
US-10590093-B2 · Mar 17, 2020 · US
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
US-2020078450-A1 · Mar 12, 2020 · US
Substituted Urea Depsipeptide Analogs as Activators of the CLPP Endopeptidase
US-2020031872-A1 · Jan 30, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC Y02A50/469?
- CPC Y02A50/469 is the Cooperative Patent Classification code for “Cross-Sectional Technologies.”
- How many patents are filed under CPC Y02A50/469 (Cross-Sectional Technologies)?
- Our database includes 49 publications tagged with this CPC code.
- Is patent activity under CPC Y02A50/469 growing?
- Publication counts under this code: 26 in 2019 vs 20 in 2020 (latest complete years).